Market Research Report
Global Prenatal Testing Market: Analysis & Forecast 2016-2022
|Published by||BIS Research Inc.||Product code||372004|
|Published||Content info||177 Pages
Delivery time: 1-2 business days
|Global Prenatal Testing Market: Analysis & Forecast 2016-2022|
|Published: September 28, 2016||Content info: 177 Pages||
With the emergence of advanced technologies such as next generation sequencing, high throughput screening (HTS), and cell free fetal DNA, there has been a rise in the overall demand of the newly developed prenatal testing. Presently, the government bodies are focused mainly towards development of non-invasive solutions, launching a large number of screening programs, controlling the increasing cases of genetic disorders, and integrating advanced technologies to fulfill the unmet needs of the patients.
Governmental regulations and standards are playing a major role in sustaining the growth and development of the market. The main aim of these regulations is to make prenatal tests and solutions more adaptable and focused towards effective diagnosis of various genetic disorders & chromosomal abnormalities. The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive accurate and proper testing and diagnosis of the disease.
This study includes an overview and analysis of the prenatal testing market, by type of tests, techniques, and geographical regions, allowing the research to develop a comprehensive outlook of the market. The prenatal testing market report presents a detailed analysis of market dynamics and provides an extensive insight into the various forms of development, trends, and key participants. All of the above mentioned report coverage parameters are discussed across different regions like North America, Europe, Asia Pacific (APAC), and Rest of the World (ROW) and further subdivided into major countries of each region. For report coverage and primaries, we have contacted industry experts and consultants in countries like U.S., U.K., Spain, China, India, Germany, Spain, France and Italy among others.
While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliances, and regulatory bodies, as well as their involvement in the prenatal testing market. The research incorporates Porter's five force model for an in-depth analysis of the prenatal testing market and an assessment of the factors governing the same. The analysis builds on a well-compiled value chain, giving a detailed understanding of the ecosystem players and their rate of market penetration.
The report includes the profiles of major players in the prenatal testing market that allows the readers to gain an insight into the various industry trends.
Prenatal testing is a series of preventive measure tests performed on expectant mothers to screen and diagnose genetic disorder in foetuses through gene mapping and sequencing of fetal cells. There are various factors that contribute towards the growth of the market for prenatal testing, such as: advanced maternal age, previous child with a chromosome abnormality, family history of chromosome abnormality, family history of single gene disorders, family history of neural tube defect and congenital structural abnormalities, abnormalities identified during pregnancy among others.
New technologies such as NGS, PCR, FISH, microarray, aCGH and MSS among others are becoming popular in the prenatal diagnosis and screening market. Evolving government initiatives, adoption by physicians, incorporation of tests into clinical care and allocation of reimbursement policies towards more genetic testing coverage are some of the major reasons which are driving the market. High pricing of screening and diagnostic tests along with the risk of accuracy causes hindrances in the growth of the market. In developing countries, most of the people do not have sufficient monetary resources for undergoing these expensive tests.
The global prenatal testing market is growing at a CAGR of 28.85% from 2016 to 2022 and is estimated to grow over $7.2 billion by 2022. Prenatal tests are classified into two main categories viz. Screening and Diagnostics. Both screening and diagnostics have witnessed an exponential growth in procuring treatments for disorders which increased in the past two decades. Screening prenatal tests are further divided into Non-Invasive Prenatal Testing Screening (NIPT) and other screening processes such as Cell-Free Foetal DNA (cffDNA), Maternal Serum Screening (MSS), Nuchal Scan (NT Procedure), Triple Test, and Quadruple Test.
The diagnostics market is further divided into two categories viz. Invasive and Non-Invasive. Invasive testing is a conventional technology amongst prenatal techniques because of which it is still leading the market. Due to low cost, invasive testing is preferred by people in developing countries, whereas the non-invasive is costly as well as comparatively a more recent technology which will take time to gain popularity. Non-invasive techniques cause no harm to the human body and thus are gaining preference amongst patients in developed regions around the world.
The U.S., the U.K., Japan, and India show a dynamic growth in the overall market due to an increasing prevalence of genetic disorders in these countries. The APAC region is focusing more on technological development and introduction of advanced tools in the field of prenatal and newborn care in order to develop specific tests and solutions.